Buy Epithalon (Epitalon) – 10mg

Epithalon 10mg Compound Specifications

Molecular Structure and Scientific Background

Epithalon is a synthetic peptide developed through research led by Professor Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology in Russia. Its molecular structure contains four amino acids arranged in a specific sequence: Ala-Glu-Asp-Gly. The compound was designed based on research involving Epithalamin, a peptide preparation derived from pineal gland tissue. Unlike Epithalamin, which contains a mixture of naturally extracted peptides, Epithalon has a defined four-amino-acid structure. This structural consistency allows researchers to investigate its molecular behavior in controlled experimental settings. Published studies have explored its interactions with cellular signaling, chromatin organization, telomerase expression, and neuroendocrine processes.

How Does Epithalon Work in Laboratory Research?

Epithalon is primarily investigated for its interaction with telomerase, an enzyme involved in maintaining the protective structures at the ends of chromosomes. These structures, known as telomeres, become progressively shorter during repeated cell division. When telomeres reach a critical length, cells may enter a state of senescence, a process in which they stop dividing. Experimental studies suggest that Epithalon may influence certain biological processes associated with telomere maintenance. However, its complete mechanism of action remains under investigation.

Telomerase Activation and Telomere Maintenance

One of the most frequently cited Epithalon studies was published by Khavinson and colleagues in 2003. Researchers examined the peptide in cultured human fetal fibroblasts that initially lacked detectable telomerase activity. The study reported that Epithalon exposure induced expression of the catalytic component of telomerase, increased enzyme activity, and promoted telomere elongation. A subsequent study in 2004 investigated its effects on the replicative capacity of cultured fibroblasts. Researchers observed that Epithalon-treated cells underwent approximately 10 additional divisions compared with untreated controls. These findings provide an experimental basis for continued investigation into the relationship between Epithalon, cellular senescence, and telomere biology. They do not demonstrate extended lifespan or anti-aging effectiveness in humans. References: Khavinson et al., 2003 and Khavinson et al., 2004.

Key Areas of Epithalon Research

1. Cellular Aging and Longevity Research

Epithalon has been examined in preclinical studies investigating biological aging, chromosome stability, and survival-related outcomes. A 2003 study published in Biogerontology evaluated the effects of Epithalon in female Swiss-derived SHR mice. Researchers observed a reduction in chromosome abnormalities and an increase in maximum lifespan in the experimental group. However, the study did not identify a significant improvement in mean lifespan or overall spontaneous tumor incidence. These findings suggest that Epithalon may influence selected age-related biological markers in experimental models. Additional research is necessary to establish the reproducibility and broader significance of these observations. Reference: Anisimov et al., 2003.

2. Pineal Gland and Circadian Rhythm Research

The pineal gland is a small neuroendocrine organ involved in producing melatonin, a hormone associated with sleep-wake cycles and biological timing. Because Epithalon was developed from pineal peptide research, scientists have investigated its potential effects on pineal signaling and circadian regulation. A study involving stress-exposed rats reported changes in C-Fos expression in pineal cells following Epithalon exposure. Other experimental research has examined how the peptide interacts with disrupted biological rhythms in animal models. Findings are not uniform. A separate study involving isolated pineal glands from young and old rats reported no significant change in melatonin secretion under its tested conditions. These findings highlight the importance of evaluating Epithalon under different experimental conditions rather than assuming a consistent effect on melatonin production. References: Sibarov et al., 2002 and Study on Pineal Melatonin Secretion.

3. Chromatin Structure and Gene Expression

Chromatin consists of DNA and associated proteins that help organize genetic material inside the cell nucleus. Its structure influences how genetic information becomes accessible during transcription and other cellular processes. A study published in Neuroendocrinology Letters investigated the interaction between Epithalon and chromatin in experimental aging models. Researchers reported changes in chromatin activity following exposure to the synthetic peptide. These observations have contributed to interest in short peptides as experimental tools for studying gene regulation and age-associated cellular changes. However, the precise molecular pathways and long-term biological implications require further investigation. Reference: Khavinson et al., 2003, Chromatin Research.

4. Oxidative Stress and Antioxidant Research

Oxidative stress occurs when reactive oxygen species exceed the capacity of a biological system to regulate them. Excessive oxidative activity can affect proteins, membrane lipids, and genetic material. Epithalon has been included in experimental research investigating antioxidant activity and the regulation of cellular defense systems. One study examined the antioxidant properties of pineal peptides in older rats. Researchers assessed antioxidant enzyme activity and biological markers associated with oxidative stress. The findings suggested that pineal peptides, including Epithalon, may influence antioxidant defense mechanisms under controlled experimental conditions. These findings remain limited to the models and conditions investigated. Reference: Antioxidant Properties of Pineal Peptides, 2007.

5. Experimental Oncology Research

Researchers have also examined Epithalon in animal models investigating age-related tumor development and cellular proliferation. The previously mentioned 2003 mouse study reported no significant difference in overall spontaneous tumor incidence between the experimental and control groups, although differences were observed for certain tumor types. Separate experimental investigations have examined its interactions with cell proliferation and apoptosis in chemically induced colon tumor models. These findings do not establish Epithalon as an anticancer compound or support therapeutic use. References: Anisimov et al., 2003 and Epitalon and Colon Carcinogenesis in Rats